Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Research Article

Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes

Author(s): Onur Uysal, Haya Erybeh, Mediha Canbek, Emilia Qomi Ekenel, Sibel Gunes, Gülay Büyükköroğlu*, Tugba Semerci Sevimli, Fatih Cemrek and Ayla Eker Sariboyaci

Volume 24, Issue 7, 2024

Published on: 19 October, 2023

Page: [906 - 919] Pages: 14

DOI: 10.2174/0115665240266016231014081916

open access plus

Abstract

Background: Cartilage injuries are currently the most prevalent joint disease. Previous studies have emphasized the use of stem cells as the effective treatment for regenerating cartilage damage.

Objective: In this study, considering the difficulties of the cellular therapy method, it was hypothesized that human synovial fluid-derived mesenchymal stem cell (hSFMSC) exosomes as a SC source could be used to treat these injuries as a safer and cell-free therapeutic alternative procedure due to its direct relevance to cartilage regeneration. Moreover, this study aimed to determine the miRNA and target genes required for the formation of SC treatment combined with gene therapy in order to reveal the mechanism of cartilage regeneration and increase its effectiveness.

Methods: MSCs were characterized by flow cytometry, and immunocytochemical and differentiation analyses were done. To characterize functionally isolated exosomes, in vitro uptake analysis was performed. RT-qPCR was used to examine in terms of the advantages of cellular and cell-free therapy, mature human chondroblasts derived by differentiation from hSF-MSCs and human chondrocyte profiles were compared in order to demonstrate the above profile of hSF-MSCs and exosomes isolated from them, and the effectiveness of SC therapy in repairing cartilage damage.

Results: According to our findings, the expression level of hsa-miR-155-5p was found to be considerably higher in chondrocytes differentiated from human synovial fluid MSCs than in mature human chondrocytes. These findings were also supported by the TGF-signalling pathway and chondrogenesis marker genes.

Conclusion: It was concluded that hSF-MSCs and exosomes can be used in the treatment of cartilage damage, and hsa-miR-155-5p can be used as a target miRNA in a new gene therapy approach because it increases the therapeutic effect on cartilage damage.

Keywords: Cartilage defects, synovial fluid mesenchymal stem cells, exosomes, chondrogenesis, hsa-miR-155-5p, fetal human chondroblast cell line.

« Previous Next »
[1]
Zhao W, Wang T, Luo Q, et al. Cartilage degeneration and excessive subchondral bone formation in spontaneous osteoarthritis involves altered TGF-β signaling. J Orthop Res 2016; 34(5): 763-70.
[http://dx.doi.org/10.1002/jor.23079] [PMID: 26496668]
[2]
Hosseini S, Taghiyar L, Safari F, Baghaban Eslaminejad M. Regenerative medicine applications of mesenchymal stem cells. Adv Exp Med Biol 2018; 1089: 115-41.
[http://dx.doi.org/10.1007/5584_2018_213] [PMID: 29767289]
[3]
Loo S, Wong N. Advantages and challenges of stem cell therapy for osteoarthritis (Review). Biomed Rep 2021; 15(2): 67.
[http://dx.doi.org/10.3892/br.2021.1443] [PMID: 34155451]
[4]
Chang C, Yan J, Yao Z, Zhang C, Li X, Mao HQ. Effects of mesenchymal stem cell‐derived paracrine signals and their delivery strategies. Adv Healthc Mater 2021; 10(7): 2001689.
[http://dx.doi.org/10.1002/adhm.202001689] [PMID: 33433956]
[5]
Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011; 50(2): 280-9.
[http://dx.doi.org/10.1016/j.yjmcc.2010.08.005] [PMID: 20727900]
[6]
Wei W, Ao Q, Wang X, et al. Mesenchymal stem cell–derived exosomes: A promising biological tool in nanomedicine. Front Pharmacol 2021; 11: 590470.
[http://dx.doi.org/10.3389/fphar.2020.590470] [PMID: 33716723]
[7]
Ferguson SW, Nguyen J. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. J Control Release 2016; 228: 179-90.
[http://dx.doi.org/10.1016/j.jconrel.2016.02.037] [PMID: 26941033]
[8]
Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: A modern approach in translational medicine. J Transl Med 2020; 18(1): 449.
[http://dx.doi.org/10.1186/s12967-020-02622-3] [PMID: 33246476]
[9]
Lai RC, Yeo RWY, Tan KH, Lim SK. Exosomes for drug delivery-a novel application for the mesenchymal stem cell. Biotechnol Adv 2013; 31(5): 543-51.
[http://dx.doi.org/10.1016/j.biotechadv.2012.08.008] [PMID: 22959595]
[10]
Shang X, Fang Y, Xin W, You H. The application of extracellular vesicles mediated mirnas in osteoarthritis: Current knowledge and perspective. J Inflamm Res 2022; 15: 2583-99.
[http://dx.doi.org/10.2147/JIR.S359887] [PMID: 35479833]
[11]
Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 2012; 3: 359.
[http://dx.doi.org/10.3389/fphys.2012.00359] [PMID: 22973239]
[12]
Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 2012; 27(8): 3037-42.
[http://dx.doi.org/10.1093/ndt/gfs168] [PMID: 22851627]
[13]
Zacharias E, Milton G, Momen-Heravi F, Hu J, Zhang X, Wu Y. Therapeutic uses of exosomes. J Circ Biomark 2013; 1(1)
[14]
Kolhe R, Hunter M, Liu S, et al. Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis. Sci Rep 2017; 7(1): 2029.
[http://dx.doi.org/10.1038/s41598-017-01905-y] [PMID: 28515465]
[15]
Iaquinta MR, Lanzillotti C, Mazziotta C, et al. The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. Theranostics 2021; 11(13): 6573-91.
[http://dx.doi.org/10.7150/thno.55664] [PMID: 33995677]
[16]
Xu C, Ren G, Cao G, et al. miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2. J Biol Chem 2013; 288(16): 11074-9.
[http://dx.doi.org/10.1074/jbc.M112.414862] [PMID: 23449975]
[17]
Pers YM, Bony C, Duroux-Richard I, et al. miR-155 contributes to the immunoregulatory function of human mesenchymal stem cells. Front Immunol 2021; 12: 624024.
[http://dx.doi.org/10.3389/fimmu.2021.624024] [PMID: 33841404]
[18]
Wang W, Rigueur D, Lyons KM. TGFβ signaling in cartilage development and maintenance. Birth Defects Res C Embryo Today 2014; 102(1): 37-51.
[http://dx.doi.org/10.1002/bdrc.21058] [PMID: 24677722]
[19]
van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis. Osteoarthritis Cartilage 2009; 17(12): 1539-45.
[http://dx.doi.org/10.1016/j.joca.2009.06.008] [PMID: 19583961]
[20]
Sariboyaci A, Uysal O, Gunes S. Differentiation of human bone marrow-derived mesenchymal stem cells into functional pancreatic beta cells. Med Sci 2021; 10(3): 951-8.
[http://dx.doi.org/10.5455/medscience.2021.07.228]
[21]
Duman BO, Sariboyaci AE, Karaoz E. Bio-engineering of 3-D cell sheets for diabetic rats: Interaction between mesenchymal stem cells and beta cells in functional islet regeneration system. Tissue Cell 2022; 79: 101919.
[http://dx.doi.org/10.1016/j.tice.2022.101919] [PMID: 36137362]
[22]
Demircan PC, Sariboyaci AE, Unal ZS, Gacar G, Subasi C, Karaoz E. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: Comparison of transwell co-culture and mixed lymphocyte reaction systems. Cytotherapy 2011; 13(10): 1205-20.
[http://dx.doi.org/10.3109/14653249.2011.605351] [PMID: 21905956]
[23]
Karaöz E, Doğan BN, Aksoy A, et al. Isolation and in vitro characterisation of dental pulp stem cells from natal teeth. Histochem Cell Biol 2010; 133(1): 95-112.
[http://dx.doi.org/10.1007/s00418-009-0646-5] [PMID: 19816704]
[24]
Sariboyaci A, Demircan P, Gacar G, Unal Z, Erman G, Karaoz E. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes? Exp Clin Endocrinol Diabetes 2014; 122(3): 179-89.
[http://dx.doi.org/10.1055/s-0034-1367004] [PMID: 25014767]
[25]
Zhou Y, Xu H, Xu W, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013; 4(2): 34.
[http://dx.doi.org/10.1186/scrt194] [PMID: 23618405]
[26]
Zhang R, Ma J, Han J, Zhang W, Ma J. Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res 2019; 11(10): 6275-89.
[PMID: 31737182]
[27]
Pan Y, Balazs L, Tigyi G, Yue J. Conditional deletion of Dicer in vascular smooth muscle cells leads to the developmental delay and embryonic mortality. Biochem Biophys Res Commun 2011; 408(3): 369-74.
[http://dx.doi.org/10.1016/j.bbrc.2011.02.119] [PMID: 21371421]
[28]
Tao SC, Yuan T, Zhang YL, Yin WJ, Guo SC, Zhang CQ. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 2017; 7(1): 180-95.
[http://dx.doi.org/10.7150/thno.17133] [PMID: 28042326]
[29]
Mao G, Zhang Z, Hu S, et al. Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A. Stem Cell Res Ther 2018; 9(1): 247.
[http://dx.doi.org/10.1186/s13287-018-1004-0] [PMID: 30257711]
[30]
Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015; 523(7559): 177-82.
[http://dx.doi.org/10.1038/nature14581] [PMID: 26106858]
[31]
Xu R, Simpson RJ, Greening DW. A protocol for isolation and proteomic characterization of distinct extracellular vesicle subtypes by sequential centrifugal ultrafiltration Exosomes and Microvesicles. Springer 2017; pp. 91-116.
[32]
Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation. Stem Cell Res Ther 2020; 11(1): 97.
[http://dx.doi.org/10.1186/s13287-020-01610-0] [PMID: 32127037]
[33]
Swingler TE, Wheeler G, Carmont V, et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 2012; 64(6): 1909-19.
[http://dx.doi.org/10.1002/art.34314] [PMID: 22143896]
[34]
Pers YM, Ruiz M, Noël D, Jorgensen C. Mesenchymal stem cells for the management of inflammation in osteoarthritis: State of the art and perspectives. Osteoarthritis Cartilage 2015; 23(11): 2027-35.
[http://dx.doi.org/10.1016/j.joca.2015.07.004] [PMID: 26521749]
[35]
Alivernini S, Gremese E, McSharry C, et al. MicroRNA-155—at the critical interface of innate and adaptive immunity in arthritis. Front Immunol 2018; 8: 1932.
[http://dx.doi.org/10.3389/fimmu.2017.01932] [PMID: 29354135]
[36]
de Kroon LMG, Narcisi R, van den Akker GGH, et al. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Sci Rep 2017; 7(1): 43164.
[http://dx.doi.org/10.1038/srep43164] [PMID: 28127051]
[37]
Green JD, Tollemar V, Dougherty M, et al. Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis 2015; 2(4): 307-27.
[http://dx.doi.org/10.1016/j.gendis.2015.09.003] [PMID: 26835506]
[38]
Guidotti S, Minguzzi M, Platano D, et al. Glycogen synthase kinase-3β inhibition links mitochondrial dysfunction, extracellular matrix remodelling and terminal differentiation in chondrocytes. Sci Rep 2017; 7(1): 12059.
[http://dx.doi.org/10.1038/s41598-017-12129-5] [PMID: 28127051]
[39]
Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor β/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28(22): 6773-84.
[http://dx.doi.org/10.1128/MCB.00941-08] [PMID: 18794355]
[40]
Wang Z, Yan K, Ge G, et al. Exosomes derived from miR-155-5p–overexpressing synovial mesenchymal stem cells prevent osteoarthritis via enhancing proliferation and migration, attenuating apoptosis, and modulating extracellular matrix secretion in chondrocytes. Cell Biol Toxicol 2021; 37(1): 85-96.
[http://dx.doi.org/10.1007/s10565-020-09559-9] [PMID: 33099657]

Rights & Permissions Print Cite
Article Metrics
82
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy